Prostate cancer, insulin, and androgen deprivation therapy

Br J Cancer. 2003 Nov 3;89(9):1814-5; author reply 1815. doi: 10.1038/sj.bjc.6601351.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Androgen Antagonists / therapeutic use*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Humans
  • Insulin / blood*
  • Male
  • Prostatic Neoplasms / blood*
  • Prostatic Neoplasms / drug therapy*
  • Risk Factors

Substances

  • Androgen Antagonists
  • Antineoplastic Agents, Hormonal
  • Insulin